Animal Healthcare Market Outlook by Product (Feed Additives, Vaccines, Pharmaceuticals, Veterinary Equipment), Animal Type (Farm, Companion), Distribution Channel (Retail, E-Commerce, Veterinary Hospitals & Clinics) - Global Industry Revenue Estimation and Demand Forecast to 2030

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segment

1.4.1. Market size breakdown, by product

1.4.2. Market size breakdown, by animal type

1.4.3. Market size breakdown, by distribution channel

1.4.4. Market size breakdown, by region

1.4.5. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

6.1. Market Dynamics

6.1.1. Trends

6.1.2. Drivers

6.1.3. Restraints/challenges

6.1.4. Impact analysis of drivers/restraints

6.2. Impact of COVID-19

6.3. Porter’s Five Forces Analysis

6.3.1. Bargaining power of buyers

6.3.2. Bargaining power of suppliers

6.3.3. Threat of new entrants

6.3.4. Intensity of rivalry

6.3.5. Threat of substitutes

Chapter 7. Global Market

7.1. Overview

7.2. Market Revenue, by Product (2017–2030)

7.2.1. Pharmaceuticals market revenue, by type (2017–2030)

7.3. Market Revenue, by Animal Type (2017–2030)

7.4. Market Revenue, by Distribution Channel (2017–2030)

7.5. Market Revenue, by Region (2017–2030)

Chapter 8. North America Market

8.1. Overview

8.2. Market Revenue, by Product (2017–2030)

8.2.1. Pharmaceuticals market revenue, by type (2017–2030)

8.3. Market Revenue, by Animal Type (2017–2030)

8.4. Market Revenue, by Distribution Channel (2017–2030)

8.5. Market Revenue, by Country (2017–2030)

Chapter 9. Europe Market

9.1. Overview

9.2. Market Revenue, by Product (2017–2030)

9.2.1. Pharmaceuticals market revenue, by type (2017–2030)

9.3. Market Revenue, by Animal Type (2017–2030)

9.4. Market Revenue, by Distribution Channel (2017–2030)

9.5. Market Revenue, by Country (2017–2030)

Chapter 10. APAC Market

10.1. Overview

10.2. Market Revenue, by Product (2017–2030)

10.2.1. Pharmaceuticals market revenue, by type (2017–2030)

10.3. Market Revenue, by Animal Type (2017–2030)

10.4. Market Revenue, by Distribution Channel (2017–2030)

10.5. Market Revenue, by Country (2017–2030)

Chapter 11. LATAM Market

11.1. Overview

11.2. Market Revenue, by Product (2017–2030)

11.2.1. Pharmaceuticals market revenue, by type (2017–2030)

11.3. Market Revenue, by Animal Type (2017–2030)

11.4. Market Revenue, by Distribution Channel (2017–2030)

11.5. Market Revenue, by Country (2017–2030)

Chapter 12. MEA Market

12.1. Overview

12.2. Market Revenue, by Product (2017–2030)

12.2.1. Pharmaceuticals market revenue, by type (2017–2030)

12.3. Market Revenue, by Animal Type (2017–2030)

12.4. Market Revenue, by Distribution Channel (2017–2030)

12.5. Market Revenue, by Country (2017–2030)

Chapter 13. U.S. Market

13.1. Overview

13.2. Market Revenue, by Product (2017–2030)

13.2.1. Pharmaceuticals market revenue, by type (2017–2030)

13.3. Market Revenue, by Animal Type (2017–2030)

13.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 14. Canada Market

14.1. Overview

14.2. Market Revenue, by Product (2017–2030)

14.2.1. Pharmaceuticals market revenue, by type (2017–2030)

14.3. Market Revenue, by Animal Type (2017–2030)

14.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 15. Germany Market

15.1. Overview

15.2. Market Revenue, by Product (2017–2030)

15.2.1. Pharmaceuticals market revenue, by type (2017–2030)

15.3. Market Revenue, by Animal Type (2017–2030)

15.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 16. France Market

16.1. Overview

16.2. Market Revenue, by Product (2017–2030)

16.2.1. Pharmaceuticals market revenue, by type (2017–2030)

16.3. Market Revenue, by Animal Type (2017–2030)

16.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 17. U.K. Market

17.1. Overview

17.2. Market Revenue, by Product (2017–2030)

17.2.1. Pharmaceuticals market revenue, by type (2017–2030)

17.3. Market Revenue, by Animal Type (2017–2030)

17.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 18. Italy Market

18.1. Overview

18.2. Market Revenue, by Product (2017–2030)

18.2.1. Pharmaceuticals market revenue, by type (2017–2030)

18.3. Market Revenue, by Animal Type (2017–2030)

18.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 19. Spain Market

19.1. Overview

19.2. Market Revenue, by Product (2017–2030)

19.2.1. Pharmaceuticals market revenue, by type (2017–2030)

19.3. Market Revenue, by Animal Type (2017–2030)

19.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 20. Japan Market

20.1. Overview

20.2. Market Revenue, by Product (2017–2030)

20.2.1. Pharmaceuticals market revenue, by type (2017–2030)

20.3. Market Revenue, by Animal Type (2017–2030)

20.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 21. China Market

21.1. Overview

21.2. Market Revenue, by Product (2017–2030)

21.2.1. Pharmaceuticals market revenue, by type (2017–2030)

21.3. Market Revenue, by Animal Type (2017–2030)

21.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 22. India Market

22.1. Overview

22.2. Market Revenue, by Product (2017–2030)

22.2.1. Pharmaceuticals market revenue, by type (2017–2030)

22.3. Market Revenue, by Animal Type (2017–2030)

22.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 23. Australia Market

23.1. Overview

23.2. Market Revenue, by Product (2017–2030)

23.2.1. Pharmaceuticals market revenue, by type (2017–2030)

23.3. Market Revenue, by Animal Type (2017–2030)

23.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 24. South Korea Market

24.1. Overview

24.2. Market Revenue, by Product (2017–2030)

24.2.1. Pharmaceuticals market revenue, by type (2017–2030)

24.3. Market Revenue, by Animal Type (2017–2030)

24.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 25. Brazil Market

25.1. Overview

25.2. Market Revenue, by Product (2017–2030)

25.2.1. Pharmaceuticals market revenue, by type (2017–2030)

25.3. Market Revenue, by Animal Type (2017–2030)

25.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 26. Mexico Market

26.1. Overview

26.2. Market Revenue, by Product (2017–2030)

26.2.1. Pharmaceuticals market revenue, by type (2017–2030)

26.3. Market Revenue, by Animal Type (2017–2030)

26.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 27. Saudi Arabia Market

27.1. Overview

27.2. Market Revenue, by Product (2017–2030)

27.2.1. Pharmaceuticals market revenue, by type (2017–2030)

27.3. Market Revenue, by Animal Type (2017–2030)

27.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 28. South Africa Market

28.1. Overview

28.2. Market Revenue, by Product (2017–2030)

28.2.1. Pharmaceuticals market revenue, by type (2017–2030)

28.3. Market Revenue, by Animal Type (2017–2030)

28.4. Market Revenue, by Distribution Channel (2017–2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and Their Offerings

29.2. Competitive Benchmarking of Key Players

29.3. Product Benchmarking of Key Players

29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. Zoetis Inc.

30.1.1. Business overview

30.1.2. Product and service offerings

30.1.3. Key financial summary

30.2. Merck & Co. Inc.

30.2.1. Business overview

30.2.2. Product and service offerings

30.2.3. Key financial summary

30.3. C.H. Boehringer Sohn AG & Co. KG

30.3.1. Business overview

30.3.2. Product and service offerings

30.3.3. Key financial summary

30.4. Bayer AG

30.4.1. Business overview

30.4.2. Product and service offerings

30.4.3. Key financial summary

30.5. Virbac Corporation

30.5.1. Business overview

30.5.2. Product and service offerings

30.5.3. Key financial summary

30.6. Ceva Santé Animale

30.6.1. Business overview

30.6.2. Product and service offerings

30.7. Heska Corporation

30.7.1. Business overview

30.7.2. Product and service offerings

30.7.3. Key financial summary

30.8. Vetoquinol S.A.

30.8.1. Business overview

30.8.2. Product and service offerings

30.8.3. Key financial summary

30.9. Elanco Animal Health Incorporated

30.9.1. Business overview

30.9.2. Product and service offerings

30.9.3. Key financial summary

30.10. Dechra Pharmaceuticals PLC

30.10.1. Business overview

30.10.2. Product and service offerings

30.10.3. Key financial summary

30.11. IDEXX Laboratories Inc.

30.11.1. Business overview

30.11.2. Product and service offerings

30.11.3. Key financial summary

30.12. Norbrook Laboratories Limited

30.12.1. Business overview

30.12.2. Product and service offerings

30.13. Phibro Animal Health Corporation

30.13.1. Business overview

30.13.2. Product and service offerings

30.13.3. Key financial summary

30.14. Hester Biosciences Limited

30.14.1. Business overview

30.14.2. Product and service offerings

30.14.3. Key financial summary

30.15. Intas Pharmaceuticals

30.15.1. Business overview

30.15.2. Product and service offerings

Chapter 31. Appendix

31.1. Abbreviations

31.2. Sources and References

31.3. Related Reports

 

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 5 GLOBAL ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 6 GLOBAL ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 7 GLOBAL PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 8 GLOBAL PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 9 GLOBAL PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 10 GLOBAL ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 11 GLOBAL ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 12 GLOBAL ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 13 GLOBAL ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 14 GLOBAL ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 15 GLOBAL ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 16 GLOBAL ANIMAL HEALTHCARE MARKET, BY REGION, $M (2017–2022)

TABLE 17 GLOBAL ANIMAL HEALTHCARE MARKET, BY REGION, $M (2023–2026)

TABLE 18 GLOBAL ANIMAL HEALTHCARE MARKET, BY REGION, $M (2027–2030)

TABLE 19 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 20 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 21 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 22 NORTH AMERICA PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 23 NORTH AMERICA PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 24 NORTH AMERICA PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 25 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 26 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 27 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 28 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 29 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 30 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 31 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2017–2022)

TABLE 32 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2023–2026)

TABLE 33 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2027–2030)

TABLE 34 EUROPE ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 35 EUROPE ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 36 EUROPE ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 37 EUROPE PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 38 EUROPE PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 39 EUROPE PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 40 EUROPE ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 41 EUROPE ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 42 EUROPE ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 43 EUROPE ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 44 EUROPE ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 45 EUROPE ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 46 EUROPE ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2017–2022)

TABLE 47 EUROPE ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2023–2026)

TABLE 48 EUROPE ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2027–2030)

TABLE 49 APAC ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 50 APAC ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 51 APAC ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 52 APAC PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 53 APAC PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 54 APAC PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 55 APAC ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 56 APAC ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 57 APAC ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 58 APAC ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 59 APAC ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 60 APAC ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 61 APAC ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2017–2022)

TABLE 62 APAC ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2023–2026)

TABLE 63 APAC ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2027–2030)

TABLE 64 LATAM ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 65 LATAM ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 66 LATAM ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 67 LATAM PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 68 LATAM PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 69 LATAM PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 70 LATAM ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 71 LATAM ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 72 LATAM ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 73 LATAM ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 74 LATAM ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 75 LATAM ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 76 LATAM ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2017–2022)

TABLE 77 LATAM ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2023–2026)

TABLE 78 LATAM ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2027–2030)

TABLE 79 MEA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 80 MEA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 81 MEA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 82 MEA PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 83 MEA PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 84 MEA PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 85 MEA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 86 MEA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 87 MEA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 88 MEA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 89 MEA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 90 MEA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 91 MEA ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2017–2022)

TABLE 92 MEA ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2023–2026)

TABLE 93 MEA ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2027–2030)

TABLE 94 U.S. ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 95 U.S. ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 96 U.S. ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 97 U.S. PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 98 U.S. PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 99 U.S. PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 100 U.S. ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 101 U.S. ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 102 U.S. ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 103 U.S. ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 104 U.S. ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 105 U.S. ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 106 CANADA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 107 CANADA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 108 CANADA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 109 CANADA PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 110 CANADA PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 111 CANADA PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 112 CANADA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 113 CANADA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 114 CANADA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 115 CANADA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 116 CANADA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 117 CANADA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 118 GERMANY ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 119 GERMANY ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 120 GERMANY ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 121 GERMANY PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 122 GERMANY PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 123 GERMANY PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 124 GERMANY ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 125 GERMANY ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 126 GERMANY ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 127 GERMANY ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 128 GERMANY ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 129 GERMANY ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 130 FRANCE ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 131 FRANCE ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 132 FRANCE ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 133 FRANCE PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 134 FRANCE PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 135 FRANCE PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 136 FRANCE ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 137 FRANCE ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 138 FRANCE ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 139 FRANCE ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 140 FRANCE ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 141 FRANCE ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 142 U.K. ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 143 U.K. ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 144 U.K. ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 145 U.K. PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 146 U.K. PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 147 U.K. PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 148 U.K. ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 149 U.K. ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 150 U.K. ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 151 U.K. ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 152 U.K. ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 153 U.K. ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 154 ITALY ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 155 ITALY ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 156 ITALY ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 157 ITALY PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 158 ITALY PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 159 ITALY PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 160 ITALY ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 161 ITALY ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 162 ITALY ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 163 ITALY ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 164 ITALY ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 165 ITALY ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 166 SPAIN ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 167 SPAIN ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 168 SPAIN ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 169 SPAIN PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 170 SPAIN PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 171 SPAIN PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 172 SPAIN ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 173 SPAIN ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 174 SPAIN ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 175 SPAIN ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 176 SPAIN ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 177 SPAIN ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 178 JAPAN ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 179 JAPAN ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 180 JAPAN ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 181 JAPAN PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 182 JAPAN PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 183 JAPAN PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 184 JAPAN ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 185 JAPAN ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 186 JAPAN ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 187 JAPAN ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 188 JAPAN ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 189 JAPAN ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 190 CHINA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 191 CHINA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 192 CHINA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 193 CHINA PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 194 CHINA PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 195 CHINA PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 196 CHINA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 197 CHINA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 198 CHINA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 199 CHINA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 200 CHINA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 201 CHINA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 202 INDIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 203 INDIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 204 INDIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 205 INDIA PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 206 INDIA PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 207 INDIA PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 208 INDIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 209 INDIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 210 INDIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 211 INDIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 212 INDIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 213 INDIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 214 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 215 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 216 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 217 AUSTRALIA PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 218 AUSTRALIA PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 219 AUSTRALIA PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 220 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 221 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 222 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 223 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 224 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 225 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 226 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 227 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 228 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 229 SOUTH KOREA PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 230 SOUTH KOREA PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 231 SOUTH KOREA PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 232 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 233 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 234 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 235 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 236 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 237 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 238 BRAZIL ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 239 BRAZIL ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 240 BRAZIL ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 241 BRAZIL PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 242 BRAZIL PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 243 BRAZIL PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 244 BRAZIL ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 245 BRAZIL ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 246 BRAZIL ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 247 BRAZIL ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 248 BRAZIL ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 249 BRAZIL ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 250 MEXICO ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 251 MEXICO ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 252 MEXICO ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 253 MEXICO PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 254 MEXICO PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 255 MEXICO PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 256 MEXICO ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 257 MEXICO ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 258 MEXICO ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 259 MEXICO ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 260 MEXICO ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 261 MEXICO ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 262 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 263 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 264 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 265 SAUDI ARABIA PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 266 SAUDI ARABIA PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 267 SAUDI ARABIA PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 268 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 269 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 270 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 271 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 272 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 273 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 274 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2022)

TABLE 275 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2023–2026)

TABLE 276 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2027–2030)

TABLE 277 SOUTH AFRICA PHARMACEUTICALS MARKET, BY TYPE, $M (2017–2022)

TABLE 278 SOUTH AFRICA PHARMACEUTICALS MARKET, BY TYPE, $M (2023–2026)

TABLE 279 SOUTH AFRICA PHARMACEUTICALS MARKET, BY TYPE, $M (2027–2030)

TABLE 280 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2022)

TABLE 281 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2023–2026)

TABLE 282 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2027–2030)

TABLE 283 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2022)

TABLE 284 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2023–2026)

TABLE 285 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2027–2030)

TABLE 286 ZOETIS INC. – AT A GLANCE

TABLE 287 ZOETIS INC. – KEY FINANCIAL SUMMARY

TABLE 288 MERCK & CO. INC. – AT A GLANCE

TABLE 289 MERCK & CO. INC. – KEY FINANCIAL SUMMARY

TABLE 290 C.H. BOEHRINGER SOHN AG & CO. KG – AT A GLANCE

TABLE 291 C.H. BOEHRINGER SOHN AG & CO. KG – KEY FINANCIAL SUMMARY

TABLE 292 BAYER AG – AT A GLANCE

TABLE 293 BAYER AG – KEY FINANCIAL SUMMARY

TABLE 294 VIRBAC CORPORATION – AT A GLANCE

TABLE 295 VIRBAC CORPORATION – KEY FINANCIAL SUMMARY

TABLE 296 CEVA SANTÉ ANIMALE – AT A GLANCE

TABLE 297 HESKA CORPORATION – AT A GLANCE

TABLE 298 HESKA CORPORATION – KEY FINANCIAL SUMMARY

TABLE 299 VETOQUINOL S.A. – AT A GLANCE

TABLE 300 VETOQUINOL S.A. – KEY FINANCIAL SUMMARY

TABLE 301 ELANCO ANIMAL HEALTH INCORPORATED – AT A GLANCE

TABLE 302 ELANCO ANIMAL HEALTH INCORPORATED – KEY FINANCIAL SUMMARY

TABLE 303 DECHRA PHARMACEUTICALS PLC – AT A GLANCE

TABLE 304 DECHRA PHARMACEUTICALS PLC – KEY FINANCIAL SUMMARY

TABLE 305 IDEXX LABORATORIES INC. – AT A GLANCE

TABLE 306 IDEXX LABORATORIES INC. – KEY FINANCIAL SUMMARY

TABLE 307 NORBROOK LABORATORIES LIMITED – AT A GLANCE

TABLE 308 PHIBRO ANIMAL HEALTH CORPORATION – AT A GLANCE

TABLE 309 PHIBRO ANIMAL HEALTH CORPORATION – KEY FINANCIAL SUMMARY

TABLE 310 HESTER BIOSCIENCES LIMITED – AT A GLANCE

TABLE 311 HESTER BIOSCIENCES LIMITED – KEY FINANCIAL SUMMARY

TABLE 312 INTAS PHARMACEUTICALS – AT A GLANCE

 

LIST OF FIGURES

FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION

FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)

FIG 8 GLOBAL ANIMAL HEALTHCARE MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 THREAT OF NEW ENTRANTS

FIG 12 INTENSITY OF RIVALRY

FIG 13 THREAT OF SUBSTITUTES

FIG 14 GLOBAL ANIMAL HEALTHCARE MARKET SNAPSHOT

FIG 15 GLOBAL ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 16 GLOBAL ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 17 GLOBAL ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 18 MAJOR WORLDWIDE MARKETS FOR ANIMAL HEALTHCARE PRODUCTS, $M

FIG 19 NORTH AMERICA ANIMAL HEALTHCARE MARKET SNAPSHOT

FIG 20 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 21 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 22 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 23 NORTH AMERICA ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2017–2030)

FIG 24 EUROPE ANIMAL HEALTHCARE MARKET SNAPSHOT

FIG 25 EUROPE ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 26 EUROPE ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 27 EUROPE ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 28 EUROPE ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2017–2030)

FIG 29 APAC ANIMAL HEALTHCARE MARKET SNAPSHOT

FIG 30 APAC ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 31 APAC ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 32 APAC ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 33 APAC ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2017–2030)

FIG 34 LATAM ANIMAL HEALTHCARE MARKET SNAPSHOT

FIG 35 LATAM ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 36 LATAM ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 37 LATAM ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 38 LATAM ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2017–2030)

FIG 39 MEA ANIMAL HEALTHCARE MARKET SNAPSHOT

FIG 40 MEA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 41 MEA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 42 MEA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 43 MEA ANIMAL HEALTHCARE MARKET, BY COUNTRY, $M (2017–2030)

FIG 44 U.S. ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 45 U.S. ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 46 U.S. ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 47 CANADA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 48 CANADA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 49 CANADA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 50 GERMANY ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 51 GERMANY ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 52 GERMANY ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 53 FRANCE ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 54 FRANCE ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 55 FRANCE ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 56 U.K. ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 57 U.K. ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 58 U.K. ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 59 ITALY ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 60 ITALY ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 61 ITALY ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 62 SPAIN ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 63 SPAIN ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 64 SPAIN ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 65 JAPAN ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 66 JAPAN ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 67 JAPAN ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 68 CHINA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 69 CHINA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 70 CHINA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 71 INDIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 72 INDIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 73 INDIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 74 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 75 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 76 AUSTRALIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 77 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 78 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 79 SOUTH KOREA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 80 BRAZIL ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 81 BRAZIL ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 82 BRAZIL ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 83 MEXICO ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 84 MEXICO ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 85 MEXICO ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 86 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 87 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 88 SAUDI ARABIA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 89 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY PRODUCT, $M (2017–2030)

FIG 90 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY ANIMAL TYPE, $M (2017–2030)

FIG 91 SOUTH AFRICA ANIMAL HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, $M (2017–2030)

FIG 92 ZOETIS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 93 MERCK & CO. INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 94 C.H. BOEHRINGER SOHN AG & CO. KG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 95 BAYER AG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 96 VIRBAC CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 97 HESKA CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 98 VETOQUINOL S.A. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 99 ELANCO ANIMAL HEALTH INCORPORATED – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 100 DECHRA PHARMACEUTICALS PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 101 IDEXX LABORATORIES INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 102 PHIBRO ANIMAL HEALTH CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 103 HESTER BIOSCIENCES LIMITED – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)